---
title: 'åä¸€é¡†å°±èƒ½æŠ—è¡°è€ï¼ç¾ä»£ç‰ˆçš„ã€Œé•·ç”Ÿä¸è€è—¥ã€å•ä¸–'
description: 'æ—©åœ¨æˆ°åœ‹æ™‚ä»£ï¼Œå°±æœ‰äº†æ‰€è¬‚æ–¹å£«ï¼ˆè¡“å£«ï¼‰ç‚ºæ»¿è¶³è«¸ä¾¯å€‘æŠ—è¡°è€é•·ç”Ÿçš„é¡˜æœ›ï¼Œæèµ·ç…‰ä¸¹çš„æ–¹è¡“ï¼Œä¼åœ–ç…‰å‡ºé•·ç”Ÿä¸è€çš„ã€Œä»™è—¥ã€ï¼Œåˆ†å…§èˆ‡å¤–å…©ç¨®æ–¹æ³•ã€‚'
pubDate: 2024-12-08
tags: ['å¥åº·', 'æŠ—è¡°è€']
---

  * ç…‰ä¸¹
  * æ˜¯æ¯’é‚„æ˜¯è—¥
  * ã€Œå»¶ç·©è€åŒ–ã€é‚„æ˜¯æ²»ç™’ã€Œè€åŒ–ã€
  * æŠ—è¡°è€è—¥çš„ç™¼å±•
  * å¡è·¯é‡Œé™åˆ¶æ¨¡æ“¬ç‰©ï¼ˆCalorie Restriction Mimeticsï¼ŒCRMï¼‰
    * æ¤ç‰©å¤šé…šï¼ˆPolyphenolsï¼‰
      * ç™½è—œè˜†é†‡ï¼ˆResveratrolï¼‰
    * è¸é¹¼é†¯èƒºè…ºå˜Œå‘¤äºŒæ ¸è‹·é…¸ï¼ˆNicotinamide Adenine Dinucleotideï¼ŒNAD+ï¼‰
    * è³€çˆ¾è’™æ–°è§£
      * 17Î±-é›ŒäºŒé†‡ï¼ˆ17Î±-Estradiolï¼‰
    * ä»£ç³–
    * è€è—¥æ–°ç”¨
      * é›·å¸•é»´ç´ ï¼ˆRapamycinï¼‰
      * äºŒç”²é›™èƒï¼ˆMetforminï¼‰
  * ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„åˆç‰©çš„èª•ç”Ÿ
  * ç¥å¥‡è—¥ä¸¸ï¼ˆMagic Pillï¼‰

## **ç…‰ä¸¹**

æ—©åœ¨æˆ°åœ‹æ™‚ä»£ï¼Œå°±æœ‰äº†æ‰€è¬‚æ–¹å£«ï¼ˆè¡“å£«ï¼‰ç‚ºæ»¿è¶³è«¸ä¾¯å€‘æŠ—è¡°è€é•·ç”Ÿçš„é¡˜æœ›ï¼Œæèµ·ç…‰ä¸¹çš„æ–¹è¡“ï¼Œä¼åœ–ç…‰å‡ºé•·ç”Ÿä¸è€çš„ã€Œ**ä»™è—¥** ã€ï¼Œåˆ†å…§èˆ‡å¤–å…©ç¨®æ–¹æ³•ã€‚

**çµå…§ä¸¹æœå¤–ä¸¹**

ã€Œ**å…§ä¸¹** ã€ï¼Œå°±æ˜¯å¾å…§åœ¨ä¾†é€šéè¡Œæ°£å°å¼•ã€å‘¼å¸åç´çš„æ–¹å¼ï¼ŒæŠŠç²¾ã€æ°£ã€ç¥åœ¨é«”å…§åŒ¯èšæˆä¸¹ï¼›ã€Œ**å¤–ä¸¹** ã€ï¼Œå°±æ˜¯ç”¨æ°´æˆ–ç«å°‡ç…‰ä¸¹çš„ææ–™é€éåŠ ç†±ã€æº¶åŒ–ã€å†·å»ç­‰ç­‰å„ç¨®æ–¹æ³•æç…‰å‡ºä¸¹è—¥ã€‚

ç”±æ–¼å…§ä¸¹å¤ªå›°é›£å¤ªæŠ½è±¡ï¼Œæ‰€ä»¥å¾Œä¾†å¤§å¤šäººéƒ½ç ”ç©¶æœé£Ÿå¤–ä¸¹ä¾†é”åˆ°é•·ç”Ÿä¸è€çš„å¤¢æƒ³ã€‚

å¤–ä¸¹ä¾ç…§æˆåˆ†çš„ä¸åŒåˆ†å‡ºè¨±å¤šæµæ´¾ï¼Œé™¤äº†ç…‰è£½é»ƒé‡‘ã€ä¸¹ç ‚çš„**é‡‘ç ‚æ´¾** ï¼Œé‚„æœ‰ä»¥é‰›æ–™ã€æ°´éŠ€ç‚ºææ–™çš„**é‰›æ±æ´¾** ï¼Œä»¥åŠå¾ç¡«é…¸å’Œæ°´éŠ€æ‰€ç…‰æˆçš„**ç¡«æ±æ´¾** ï¼›

è€Œç…‰è£½çš„æ–¹æ³•ï¼Œé‚„å€åˆ†ã€Œ**ç«æ³•** ã€èˆ‡ã€Œ**æ°´æ³•** ã€å…©ç¨®ã€‚ã€Œç«æ³•ã€åŒ…æ‹¬ï¼šæ®µã€ç…‰ã€ç‚™ã€ç†”ã€æŠ½ã€é£›ã€ä¼ç­‰ç­‰ï¼Œã€Œæ°´æ³•ã€åŒ…æ‹¬ï¼šåŒ–ã€æ·‹ã€å°ã€ç…®ã€ç†¬ã€é¤Šã€æ¾†ã€æ¼¬ã€é‡€ã€é»ç­‰æ–¹æ³•ã€‚

ç…‰ä¸¹çš„é¼

## **æ˜¯æ¯’é‚„æ˜¯è—¥**

åˆ°äº†æ±æ¼¢æ™‚æœŸï¼Œç¬¬ä¸€æœ¬ç‚ºç…‰ä¸¹è¡“ç«‹è«–çš„è‘—ä½œçµ‚æ–¼å•ä¸–ï¼Œåç‚ºã€Šå‘¨æ˜“åƒåŒå¥‘ã€‹ã€‚

å¤æ™‚ä¹Ÿåªæœ‰çš‡å¸æ‰èƒ½æœ‰æ©Ÿæœƒåƒä»™ä¸¹ã€‚å¤ä»£ä»™ä¸¹å¤šå«æœ‰ç ’éœœæˆ–æ˜¯æ°´éŠ€ã€éŠ…ç­‰é‡é‡‘å±¬ï¼Œä¸€åƒå°±æ›´å¿«ä¸­æ¯’è€Œä¸€å‘½å—šå‘¼ã€‚

è€Œå”ä»£æ˜¯ç…‰ä¸¹è¡“çš„å…¨ç››æ™‚æœŸï¼Œå”é«˜å®—ã€å”ç„å®—ç­‰éƒ½æ›¾è¦ªè‡ªé¸æ‹›æ–¹å£«ã€é“å£«é€²å®®é€²è¡Œã€ŒåŒ–é»ƒé‡‘ï¼Œå†¶ä¸¹æ³•ã€‚ã€ï¼Œæ‰€ä»¥ä¹Ÿæ˜¯çš‡å¸æ­»äº¡æ•¸ç›®æœ€å¤šçš„ä¸€å€‹ç‹æœ**ã€‚**

æ ¹æ“šçµ±è¨ˆï¼Œåœ¨ä¸­åœ‹æ­·å²ä¸Šåƒä¸¹è—¥è€Œäº¡ä¸”è‡ªèº«èµ«èµ«æœ‰åçš„çš„çš‡å¸åˆ†åˆ¥æœ‰ï¼š

çš‡å¸| äº«å¹´  
---|---  
æ™‰å“€å¸å¸é¦¬ä¸•| 25 æ­²  
å”å¤ªå®—æä¸–æ°‘| 51 æ­²  
å”ç©†å®—ææ†| 30 æ­²  
å”æ­¦å®—æç‚| 33 æ­²  
å”å®£å®—æå¿±| 50 æ­²  
å—å”çƒˆç¥–ææ˜ª| 56 æ­²  
æ˜ä»å®—æœ±é«˜ç†¾| 47 æ­²  
æ˜ä¸–å®—æœ±åšç’| 60 æ­²  
æ˜å…‰å®—æœ±å¸¸æ´›| 39 æ­²  
æ˜ç†¹å®—æœ±ç”±æ ¡| 23 æ­²  
æ¸…ä¸–å®—æ„›æ–°è¦ºç¾…ï¼èƒ¤ç¦›| 58 æ­²  
  
å› ç…‰ä¸¹è€Œäº¡çš„çš‡å¸

æƒ³è¦é•·å£½çš„åè€Œéƒ½æ—©äº¡ã€‚

## **ã€Œå»¶ç·©è€åŒ–ã€é‚„æ˜¯æ²»ç™’ã€Œè€åŒ–ã€**

é€™æ™‚å€™æˆ‘å€‘è¦å•è‡ªå·±ä¸€å€‹å•é¡Œï¼š

**ã€Œè€åŒ–ã€æ˜¯ä¸€å€‹éç¨‹ï¼Œé‚„æ˜¯ä¸€å€‹ç–¾ç—…ï¼Ÿ**

æœ‰äººèªªäººæ€éº¼å¯èƒ½ä¸è®Šè€ï¼Ÿè®Šè€æ˜¯å¤©ç¶“åœ°ç¾©çš„äº‹ï¼Œå†æ­£å¸¸ä¸éäº†ã€‚

ä¸éå¾æœ€è¿‘äºŒã€ä¸‰åå¹´çš„ç§‘å­¸ç ”ç©¶é€²å±•ä¾†èªªï¼Œç¾åœ¨å¾ˆå¤šç ”ç©¶è€å¹´é†«å­¸çš„ç§‘å­¸å®¶èªç‚ºï¼Œè¡°è€å¾ˆæœ‰å¯èƒ½åªæ˜¯**åŸºå› ç·¨ç¢¼** çš„ç¨‹åºæ¼¸æ¼¸å¤±æ•ˆï¼ŒæŠ—è¡°è€ä¸¦éåšä¸åˆ°ã€‚

ç†è«–ä¸Šï¼Œäººé¡åªè¦èƒ½ã€Œ**æŒçºŒ** ã€ä¿®å¾©é«”å…§å—æçš„åˆ†å­åŠç´°èƒä¾¿èƒ½ä¸æ­»ã€‚äººé«”åœ¨æ–°é™³ä»£è¬éç¨‹ä¸­æœƒç´¯ç©ã€Œåƒåœ¾ã€â€”ç™¼ç‚ç‰©è³ªï¼Œå½±éŸ¿åˆ°ç´°èƒæ­£å¸¸é‹ä½œï¼Œåªè¦èƒ½å®šæœŸæ¸…é™¤é«”å…§åƒåœ¾ä¾¿å¯æ´»ä¸‹å»ã€‚

æœ€å®Œæ•´çš„æŠ—è¡°è€æ–¹æ³•è«‹çœ‹é€™ä¸€ç¯‡ï¼š

ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [é›†æŠ—è¡°è€è¿‘ç™¾å¹´ç ”ç©¶å¤§æˆâ€”å‚³æ‰¿è‡ªç†±é‡é™åˆ¶æ³•ä¹‹ageLOCæŠ€è¡“çš„èª•ç”Ÿ](https://agelocked.com/%e9%9b%86%e6%8a%97%e8%a1%b0%e8%80%81%e8%bf%91%e7%99%be%e5%b9%b4%e7%a0%94%e7%a9%b6%e5%a4%a7%e6%88%90-%e5%82%b3%e6%89%bf%e8%87%aa%e7%86%b1%e9%87%8f%e9%99%90%e5%88%b6%e6%b3%95%e4%b9%8bageloc/)

## **æŠ—è¡°è€è—¥çš„ç™¼å±•**

å› ç‚ºç„¡æ³•ä½¿ç”¨äººé¡ä¾†åšç ”ç©¶ï¼Œæˆ‘å€‘åªèƒ½å¾å‰äººçš„ç´€éŒ„ä¾†çªºæ¢ä¸€äºŒï¼Œä¸€ç›´åˆ°è¥¿å…ƒ 1915 å¹´ç¶“éç§‘å­¸å®¶ç ”ç©¶å¾Œæ‰æ…¢æ…¢é–‹å•Ÿæ­é–‹è€åŒ–çš„é—œéµã€‚

åœ¨ 1930 å¹´ä»£ï¼Œåœ¨ç•¶æ™‚æœ‰è‘—é–‹å‰µæ€§ç‡Ÿé¤Šç ”ç©¶â€”**å¡è·¯é‡Œé™åˆ¶æ³•** ï¼ˆCalorie Restrictionï¼ŒCRï¼‰ï¼Œä¹Ÿç¨±ç‚º**é£²é£Ÿé™åˆ¶æ³•** ï¼ˆ  
Dietary Restrictionï¼‰æˆ–**ç‡Ÿé¤Šé™åˆ¶æ³•** ï¼ˆNutrient Restrictionï¼‰ã€‚

æ ¹æ“šå‹•ç‰©ç ”ç©¶é¡¯ç¤ºï¼Œå¦‚æœæŠŠä¸€å¤©é£²é£Ÿæ‰€éœ€çš„å¡è·¯é‡Œ**æ¸›å°‘äº† 30 ~ 50 ï¼…** ï¼Œå¯ä»¥å»¶é•·å£½å‘½ã€æ¸›å°‘ç™¼ç—…ç‡ä¸¦å»¶ç·©èˆ‡å¹´é½¡æœ‰é—œçš„ç–¾ç—…çš„ç™¼ä½œä¸¦æ¸›ç·©å„å™¨å®˜åŠŸèƒ½è¡°é€€ã€‚

ä¸€ç›´åˆ°ç¾åœ¨ç ”ç©¶ç™¼ç¾ï¼Œå…¶ä¸­

  * **Sirtuin æŒç®¡ç´°èƒç”Ÿå­˜ã€ä»£è¬èˆ‡å£“åŠ›åæ‡‰**
  * **AMPK æ˜¯ç´°èƒä¸­èª¿æ§èƒ½é‡å¹³è¡¡æœ‰é—œ**
  * **mTOR èª¿ç¯€è›‹ç™½è³ªæ–°é™³ä»£è¬è¨Šæ¯**
  * **PPARs å’Œè„‚è‚ªçš„åˆæˆå’Œç¢³æ°´åŒ–åˆç‰©çš„ä»£è¬ä½œç”¨æœ‰é—œ**
  * **NfR2 æŠ—æ°§åŒ–ã€æ¸›å°‘ç™¼ç‚ã€æŠ—ç™Œæœ‰é—œ**

é€™å¹¾æ¢æ§åˆ¶è¡°è€è·¯å¾‘ç‰½æ¶‰åˆ°è¨±å¤šé‡è¦ç”Ÿç†éç¨‹ï¼Œå½¼æ­¤ç›¸äº’å½±éŸ¿ã€‚

è‹¥èƒ½æ”¹å–„ä¸Šè¿°èƒ½é‡å‚³éè·¯å¾‘ã€è›‹ç™½è³ªåˆæˆè¡¨ç¾ã€ç«¯ç²’é•·åº¦ç­‰ç­‰æŒ‡æ¨™ï¼Œå°±æœ‰æ©Ÿæœƒæˆç‚ºæœªä¾†æœ‰æ•ˆçš„æŠ—è¡°è€è—¥ã€‚

å³ä½¿ç§‘å­¸å¯ä»¥è­‰æ˜ï¼Œäººé¡ä½¿ç”¨**é£²é£Ÿé™åˆ¶** å¯ä»¥é™ä½ç™¼ç—…ç‡å’Œæ­»äº¡ç‡ï¼Œä½†å•é¡Œæ˜¯æˆ‘å€‘é¡˜æ„**é•·æ™‚é–“ç¶­æŒ** é€™æ¨£åšå—ï¼Ÿ

## **å¡è·¯é‡Œé™åˆ¶æ¨¡æ“¬ç‰©ï¼ˆCalorie Restriction Mimeticsï¼ŒCRMï¼‰**

è€ƒæ…®åˆ°é›£ä»¥é•·æœŸç¶­æŒçš„å›°é›£ã€é£¢é¤“æ„Ÿã€æ€§æ…¾çš„ä¸‹é™ï¼Œç§‘å­¸å®¶å°æ–¼å°‹æ‰¾å¡è·¯é‡Œé™åˆ¶æ³•æ›¿ä»£å“æˆ–**å¡è·¯é‡Œé™åˆ¶æ¨¡æ“¬ç‰©** ï¼ˆCalorie Restriction Mimeticsï¼ŒCRMï¼‰ç”¢ç”Ÿæ¥µå¤§çš„èˆˆè¶£ï¼Œå¸Œæœ›é€™äº›æ›¿ä»£å“å¯ä»¥æä¾›å¡è·¯é‡Œé™åˆ¶æ³•çš„é•·å£½ç›Šè™•ï¼Œè€Œä¸é ˆæ§åˆ¶ç†±é‡çš„æ”å…¥ã€‚

è€Œé€éé€™å¹¾å¹´ä¾†çš„ç ”ç©¶ï¼Œèˆ‡æŠ—è¡°è€ç›¸é—œçš„è¨Šæ¯é€šè·¯ç†è§£ï¼Œå°æ–¼å¡è·¯é‡Œé™åˆ¶æ¨¡æ“¬ç‰©æœ‰æ›´å¤šçš„å€™é¸ï¼š

###   
**æ¤ç‰©å¤šé…šï¼ˆPolyphenolsï¼‰**

æ¤ç‰©å¤šé…šä½œç‚ºå¤©ç„¶æŠ—æ°§åŒ–ç‰©è³ªï¼Œé€™äº›æŠ—æ°§åŒ–ç‰©è³ªæœƒé€²å…¥ç´°èƒè†œå…§ï¼Œä¿è­·æ©Ÿé«”çµ„ç¹”æŠµå¾¡æ´»æ€§æ°§çš„æ”»æ“Šï¼Œå¯ä»¥é€šé Nrf2/ARE è¨Šæ¯é€šè·¯ï¼Œèª¿ç¯€è©²ç´°èƒå…§ä¿¡è™Ÿå‚³å°åˆ†å­çš„æ´»æ€§ï¼Œå¢å¼·æŠ—æ°§åŒ–åŸºå› æˆ–è›‹ç™½çš„è¡¨é”ï¼Œæé«˜ç´°èƒæŠ—æ°§åŒ–å£“åŠ›çš„èƒ½åŠ›ã€‚

#### **ç™½è—œè˜†é†‡ï¼ˆResveratrolï¼‰**

è¥¿å…ƒ 1939 å¹´æ—¥æœ¬**åŒ—æµ·é“å¤§å­¸** ï¼ˆHokkaido Universityï¼‰**é«˜å²¡é“å¤«** ï¼ˆã«ã‚ˆã£ã¦ ï¼ŒMichio Takaokaï¼‰æ•™æˆç¬¬ä¸€æ¬¡åœ¨æœ‰æ¯’æ¤ç‰©è—œè˜†**ç™½è—œè˜†** _ï¼ˆVeratrum album_ ï¼‰çš„æ¤ç‰©æ ¹è–ç™¼ç¾**ç™½è—œè˜†é†‡** é€™æˆåˆ†ï¼Œä½†ç•¶æ™‚å°šæœªå¼•èµ·å»£æ³›é‡è¦–ã€‚é›–ç„¶å®ƒä¸æ˜¯æœ‰æ¯’æˆåˆ†ï¼Œä½†ç”±æ–¼å…¶çµæ§‹èˆ‡**é–“è‹¯äºŒé…š** ï¼ˆResorcinolï¼‰ç›¸ä¼¼è€Œè¢«å‘½åç‚ºç™½è—œè˜†é†‡ã€‚

ç´…é…’ä¸­ç™¼ç¾çš„ç™½è—œè˜†é†‡èˆ‡æ³•åœ‹æ‚–è«–æœ‰é—œï¼Œé¡¯ç¤ºå°å¿ƒè¡€ç®¡ç–¾ç—…æœ‰æ½›åœ¨çš„é é˜²ä½œç”¨ã€‚è¥¿å…ƒ 2006 å¹´æ¾³æ´²ç§‘å­¸å®¶**å¤§è¡›ï¼å®‰å¾·é­¯ï¼è¾›å…‹èŠ** ï¼ˆDavid Andrew Sinclairï¼‰åœ¨ã€Šè‡ªç„¶ã€‹é›œèªŒç™¼è¡¨çš„ä¸€é …ç ”ç©¶å®£å¸ƒç™½è—œè˜†é†‡èƒ½ä½¿èˆ‡äººé¡ç›¸ä¼¼çš„å“ºä¹³å‹•ç‰©å£½å‘½å»¶é•·ï¼Œç ”ç©¶é¡¯ç¤ºä»–å¯ä»¥æŠ‘åˆ¶ Sirtuin ä½œç”¨ï¼Œå› è€Œè²åå¤§å™ªã€‚

éš”å¹´è¥¿å…ƒ 2007 å¹´ä»–èˆ‡å‰µæŠ•å®¶**å…‹é‡Œæ–¯æ‰˜å¤«ï¼è¡›æ€å¼—** ï¼ˆChristoph Westphalï¼‰åˆè³‡æˆç«‹çš„ç”Ÿç‰©å…¬å¸ Sirtris Pharmaceuticalsï¼Œå¸Œæœ›è—‰ç”±å¤§é‡å°åˆ†å­çš„ç¯©é¸ï¼Œèƒ½æ‰¾å‡ºèƒ½å¤ æ¯”ç™½è—œè˜†é†‡æ•ˆæœå¥½ 1000 å€çš„é…µç´ åŠŸæ•ˆï¼Œä¸¦ä¸”èƒ½ç”¨åœ¨å“ºä¹³é¡å‹•ç‰©ä¸Šã€‚çœ‹å¥½é€™å€‹è¶¨å‹¢ï¼Œè¥¿å…ƒ 2008 å¹´**è‘›è˜­ç´ å²å…‹è—¥å» ** ï¼ˆGlaxoSmithKlineï¼ŒGSKï¼‰ä»¥è¶…éä¸ƒå„„å…©åƒè¬ç¾å…ƒçš„ä»£åƒ¹ä½µè³¼é€™å®¶å…¬å¸ã€‚

ç ”ç©¶åˆ°ç›®å‰ç‚ºæ­¢ï¼Œæœ‰è¨±å¤šé—œæ–¼ç™½è—œè˜†é†‡çš„ç ”ç©¶å ±å‘ŠæŒ‡å‡ºï¼Œç™½è—œè˜†é†‡åœ¨é«”å¤–å’Œé«”å…§å‡è¡¨ç¾å‡ºå¤šç¨®ç”Ÿç†æ´»æ€§ï¼ŒåŒ…æ‹¬æŠ—ç™Œã€æŠ—æ°§åŒ–å’ŒæŠ—ç‚ç­‰åŠŸæ•ˆï¼Œå°å„ç¨®æ¨¡å¼ç”Ÿç‰©ï¼ˆåŒ…æ‹¬é…µæ¯ã€ç·šèŸ²ã€è’¼è …å’Œé­šé¡ï¼‰çš„ç ”ç©¶å ±å‘Šäº†å£½å‘½å»¶é•·çš„æ•ˆæœã€‚ 

### **è¸é¹¼é†¯èƒºè…ºå˜Œå‘¤äºŒæ ¸è‹·é…¸ï¼ˆNicotinamide Adenine Dinucleotideï¼ŒNAD +ï¼‰**

NAD+ æ˜¯ä¸€ç¨®å‚³éæ°«é›¢å­çš„è¼”é…¶ï¼Œå®ƒå‡ºç¾åœ¨ç´°èƒå¾ˆå¤šä»£è¬åæ‡‰ï¼Œå°¤å…¶åœ¨ç²’è…ºé«”å…§ã€‚åœ¨ 40åˆ° 60 æ­²äººçš„è¡€æ¶²ä¸­å®ƒç”šè‡³æœƒä¸‹é™åˆ°åŸä¾†çš„ 50 %ã€‚

éå»çš„ç ”ç©¶ç™¼ç¾å¹´è¼•å°é¼ æ¯”å¹´è€å°é¼ é«”å…§å«æœ‰è¼ƒå¤šçš„ NAD+ã€‚è¥¿å…ƒ 2013 å¹´è¾›å…‹èŠï¼ˆå°ï¼Œé‚„æ˜¯è®“è‘›è˜­ç´ è—¥å» èŠ± 7 å„„ç¾é‡‘çš„é‚£ä½ï¼‰åœ¨ã€Šç´°èƒã€‹æœŸåˆŠä¸Šç™¼è¡¨èªª NMN å¯ä»¥åœ¨é«”å…§è½‰åŒ–ç‚º NAD+ ï¼Œè€Œåœ¨é£Ÿç‰©ä¸­ç•ªèŒ„ã€é…ªæ¢¨ã€èŠ±æ¤°èœç­‰éƒ½åªå«æœ‰å°‘é‡çš„ NMNï¼Œæ‰€ä»¥è¦é é¡å¤–çš„è£œå……ã€‚

è€Œåœ¨è¥¿å…ƒ 2017å¹´ï¼Œä»–åˆåœ¨ã€Šç§‘å­¸ã€‹é›œèªŒä¸Šç™¼è¡¨èªªå¹´é•·çš„å°é¼ åœ¨è£œå…… NMN ä¹‹å¾Œï¼Œå¹´é•·çš„å°é¼ ç´°èƒä¿®å¾© DNA æå‚·çš„èƒ½åŠ›æé«˜äº†ã€‚

äººé«”å¤šç¨®çµ„ç¹”ä¸­çš„ NAD+ æ¿ƒåº¦æœƒéš¨è‘—å¹´é½¡å¢é•·è€Œä¸‹é™ï¼Œè¾›å…‹èŠåšå£«ä»–è¦ºå¾—å¦‚æœèƒ½é€šéè£œå…… NAD+ æ–¹å¼æ¢å¾© NAD+ æ¿ƒåº¦çš„è©±ï¼Œèº«é«”çš„æŠ—è¡°è€èƒ½åŠ›å°±æœƒå¤§å¤§çš„å¢åŠ ã€‚æ–¼æ˜¯ä»–åœ¨æ³¢å£«é “å‰µç«‹äº† MetroBiotech å…¬å¸ï¼Œä¾¿è‡´åŠ›æ–¼ç ”ç©¶ NAD+ åœ¨äººé«”å¯¦é©—çš„æ•ˆæœã€‚

ä»–ç ”ç™¼äº†ä¸€ç¨®å«æœ‰ä¸€ç¨®åå«**è¸é¹¼é†¯èƒºå–®æ ¸è‹·é…¸** ï¼ˆNicotinamide Mononucleotideï¼ŒNMNï¼‰çš„è† å›Šã€‚ NMN æ˜¯ NAD+ çš„å‰é©…ç‰©ï¼Œåœ¨å‹•ç‰©å¯¦é©—ä¸­ NMN èƒ½å¤ è¿…é€Ÿçš„æå‡ç´°èƒå…§ NAD+ çš„æ¿ƒåº¦è€Œä¸”å¾ˆå®‰å…¨ã€‚

MetroBiotech

è¥¿å…ƒ 2017å¹´ï¼Œé¦™æ¸¯å¯Œè±ªæå˜‰èª ä¹Ÿå°æ–¼ä¸€å®¶å°ˆé–€ç ”ç™¼**è¸é¹¼é†¯èƒºæ ¸ç³–** ï¼ˆNicotinamide Ribosideï¼ŒNR ä¹Ÿæ˜¯ NAD+ å‰é©…ç‰©çš„ä¸€ç¨®ï¼‰ä¿å¥å“çš„ ChromaDex å…¬å¸æŠ•è³‡äº† 2500 è¬ç¾é‡‘ï¼Œåœ¨ä¸­åœ‹ä¸€ç‰‡ç˜‹å‚³ã€Œåªè¦æçˆºçˆºé‚„æ´»è‘—ï¼Œæˆ‘å°±ä¿¡é€™ç“¶è—¥çœŸçš„æœ‰ä½œç”¨ã€‚ã€ã€‚

ChromaDex

NMN è©³ç´°ä»‹ç´¹å¯ä»¥çœ‹é€™ä¸€ç¯‡ï¼š

ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡

> [æŠ—è¡°è€æ˜æ˜Ÿ NMN çœŸçš„èƒ½é”åˆ°æŠ—è¡°è€çš„ç›®çš„å—ï¼Ÿ](https://agelocked.com/%e6%8a%97%e8%a1%b0%e8%80%81%e6%98%8e%e6%98%9f-nmn-%e7%9c%9f%e7%9a%84%e8%83%bd%e9%81%94%e5%88%b0%e6%8a%97%e8%a1%b0%e8%80%81%e7%9a%84%e7%9b%ae%e7%9a%84%e5%97%8e%ef%bc%9f/)

å¤šé…šé¡**å…·æœ‰å¼·åŠ›çš„æŠ—æ°§åŒ–ä½œç”¨ï¼Œ** å› æ­¤è¢«è¦–ç‚ºæœªä¾†æœ€å…·å»¶ç·©è€åŒ–çš„æŠ—è€ç‰©è³ªã€‚ åƒ**å°æª—é¹¼** ï¼ˆBerberineï¼‰ã€**å…’èŒ¶ç´ ** ï¼ˆCatechinï¼‰ã€**è–‘é»ƒç´ ** ï¼ˆCurcuminï¼‰ã€**æ²’é£Ÿå­é…¸** ï¼ˆGallic Acidï¼‰ã€**æ¥Šæ¢…é»ƒé…®** ï¼ˆMyricetinï¼‰ã€**æªçš®ç´ ** ï¼ˆQuercetinï¼‰ç›®å‰æœ‰å¤šé …ç ”ç©¶é¡¯ç¤ºæœ‰è‰¯å¥½çš„æŠ—è¡°è€æ½›åŠ›ã€‚

### **è³€çˆ¾è’™æ–°è§£**

äººé«”çš„å…§åˆ†æ³Œç³»çµ±æ˜¯ä¸»æŒäººé«”ç”Ÿç†åŠŸèƒ½æ­£å¸¸é‹ä½œçš„ä¸‰å¤§ç³»çµ±ä¹‹ä¸€ï¼Œæ›´èˆ‡æŠ—è€åŒ–æ¯æ¯ç›¸é—œã€‚ç”±å…§åˆ†æ³Œè…ºæ‰€åˆ†æ³Œçš„åŒ–å­¸ç‰©è³ªå°±æ˜¯æ¿€ç´ ï¼Œä¹Ÿç¨±ç‚ºè·çˆ¾è’™ï¼Œæ˜¯ä¸€ç¨®åŒ–å­¸å‚³å°ç‰©è³ªï¼Œè‡ªè…ºé«”åˆ†æ³Œå‡ºä¾†å¾Œï¼Œè—‰ç”±é«”æ¶²æˆ–è¡€æ¶²å‚³é€è‡³èº«é«”å„éƒ¨ä½ï¼Œèª¿ç¯€å„é …ç”Ÿç†åŠŸèƒ½ã€‚

#### **17Î±-é›ŒäºŒé†‡ï¼ˆ17Î±-Estradiolï¼‰**

è½åˆ°é€™å€‹åè©ä»¥ç‚ºæ˜¯ã€Œå¥³æ€§å°ˆç”¨ã€å—ï¼Ÿå…ˆåˆ¥ç·Šå¼µï¼ 17Î±-é›ŒäºŒé†‡ä¹Ÿè¢«ç¨±ç‚º **17-è¡¨é›ŒäºŒé†‡** ï¼ˆ17-epiestradiolï¼‰ï¼Œé›–ç„¶ 17Î±-é›ŒäºŒé†‡æ˜¯é›Œæ¿€ç´ çš„ä¸€ç¨®ï¼Œä½†æ˜¯é€™å€‹ä¸æ˜¯æˆ‘å€‘å¹³å¸¸æ‰€èªç‚ºçš„é›Œæ¿€ç´ å–”ï¼

é›Œæ¿€ç´ åŒ…æ‹¬**é›ŒäºŒé†‡** ï¼ˆestradiolï¼‰ã€**é›Œé…®** ï¼ˆestroneï¼‰ã€**é›Œä¸‰é†‡** ï¼ˆestriolï¼‰ï¼Œå…¶ä¸­é›ŒäºŒé†‡å«é‡æœ€å¤šï¼Œæ´»æ€§ä¹Ÿæœ€å¼ºã€‚

å¥³æ€§è³€çˆ¾è’™

é›ŒäºŒé†‡åˆå¯ä»¥åˆ†ç‚º 17Î±-é›ŒäºŒé†‡å’Œ 17Î²-é›ŒäºŒé†‡å…©ç¨®ï¼Œä»–å€‘åˆ†å­å¼ç›¸åŒï¼Œä½†æ˜¯åœ¨åŒ–å­¸çµæ§‹ä¸Šä¸åŒã€‚

å¦å¤– 17Î±-é›ŒäºŒé†‡çš„é›Œæ¿€ç´ æ•ˆåƒ¹å¼·åº¦åªæœ‰ 17Î²-é›ŒäºŒé†‡ï¼ˆ 17Î²-é›ŒäºŒé†‡æ‰æ˜¯æˆ‘å€‘é€šå¸¸ç°¡ç¨±ç‚ºé›Œæ¿€ç´ ï¼‰çš„ç™¾åˆ†ä¹‹ä¸€ï¼Œä¸”æ›´è¦ªå’Œé›Œæ¿€ç´ å—é«”ä¸­çš„ERÎ±ï¼Œè€ŒéERÎ²ã€‚

å› æ­¤ç›¸å° 17Î²-é›ŒäºŒé†‡è€Œè¨€ï¼Œå¤§å®¶èªç‚ºå®ƒæ˜¯ä¸€ç¨®éé›ŒåŒ–çš„é›Œæ¿€ç´ ï¼Œè£œå…… 17Î±-é›ŒäºŒé†‡ä¸æœƒå°è‡´ç¬¬äºŒæ€§å¾µç™¼è‚²ï¼Œè®“ç”·æ€§å¥³æ€§åŒ–ï¼Œå¥³æ€§æ›´åŠ å¥³æ€§åŒ–ï¼ˆç”·ç”Ÿå¯ä»¥æ”¾å¿ƒäº†ï¼Œæ›´ä½•æ³èº«é«”å…§é‚„æœ‰**çªå›ºé…®** ï¼ˆTestosteroneï¼‰ï¼‰ã€‚

17Î±-estradiol èˆ‡17 Î²-estradiol ä¸åŒ

åœ¨è¥¿å…ƒ 2016 å¹´å‹•ç‰©å¯¦é©—è­‰å¯¦å¯ä»¥å»¶é•· 19 % å…¬é¼ å£½å‘½ï¼Œä¸éæ¯é¼ å£½å‘½é•·åº¦ä¸å—å½±éŸ¿ã€‚

è€Œåœ¨è¥¿å…ƒ 2021 å¹´å‹•ç‰©å¯¦é©—ä¸­ï¼ŒæŠŠæœˆé½¡ 16 å€‹æœˆèˆ‡ 20 å€‹æœˆçš„å°é¼ ï¼ˆç›¸ç•¶æ–¼ä¸­å¹´ç”·æ€§ï¼‰é£²é£Ÿä¸­æ·»åŠ  17Î±-é›ŒäºŒé†‡ï¼Œé›„æ€§å°é¼ å¹³å‡å£½å‘½åˆ†åˆ«æå‡ 19 % å’Œ 11 % ï¼çµæœæ˜¯ã€Œ**ç”·æ€§å°ˆå±¬çš„æ•ˆæœ** ã€ï¼

å¯¦é©—æå‡é›„æ€§é¼ ç”Ÿå‘½

### **ä»£ç³–**

åƒå¤ªå¤šç³–æœƒå¼•èµ·ä»£è¬ç—‡å€™ç¾¤ï¼Œäººæœªè€å…ˆè¡°ã€‚åœ¨è¥¿å…ƒ 2018 å¹´åœ‹æ°‘å¥åº·ç½²ç™¼å¸ƒæ–°ç‰ˆã€Œåœ‹æ°‘é£²é£ŸæŒ‡æ¨™ã€ä¸­å¢åˆ—ã€Œæ¯æ—¥é£²é£Ÿä¸­ï¼Œ**æ·»åŠ ç³–** æ”å–é‡ä¸å®œè¶…éç¸½ç†±é‡çš„ 10 % ã€ä¹‹å»ºè­°ã€‚

æ·»åŠ ç³–æŒ‡åœ¨è£½é€ æˆ–è£½å‚™é£Ÿç‰©èˆ‡é£²æ–™æ™‚é¡å¤–æ·»åŠ çš„ç³–ï¼ŒåŒ…æ‹¬é»‘ç³–ã€è”—ç³–ã€ç³–éœœã€è‘¡è„ç³–ã€ç ‚ç³–ã€ç™½ç³–ã€ç‰ç±³ç³–æ¼¿ã€èœ‚èœœã€æ¥“ç³–æ¼¿ç­‰ï¼Œä¸åŒ…æ‹¬äººå·¥ç”œå‘³åŠ‘åŠè‡ªç„¶å­˜åœ¨é£Ÿç‰©å…§çš„ç³–ï¼Œä¾‹å¦‚ç‰›å¥¶å’Œæ°´æœä¸­çš„ç³–ã€‚åŠ ç³–æ”å–é‡ä¸å®œè¶…éç¸½ç†±é‡çš„ 10 %ã€‚

æ¯æ—¥æ·»åŠ ç³–ä¸Šé™

ç¾åœ¨å¤–å¸¶é£²æ–™ä¸€æ¯ã€Œå…¨ç³–ã€çš„çç å¥¶èŒ¶å°±é é è¶…é 50 å…¬å…‹ï¼Œæ‰€ä»¥å¤§å®¶éƒ½æŠŠè…¦ç­‹å‹•åˆ°ã€Œä»£ç³–ã€ä¸Šã€‚ä»£ç³–å¹¾ä¹ä¸æœƒè¢«äººé«”æ¶ˆåŒ–å¸æ”¶ï¼Œä¹Ÿä¸æœƒå¼•èµ·è¡€ç³–çš„æ³¢å‹•ï¼Œå› æ­¤æ²’æœ‰é¡å¤–ç†±é‡ç”¢ç”Ÿã€‚

ä»£ç³–å¤§ç´„å¯åˆ†é€™ä¸‰é¡ï¼š

**â‘ ****ç‡Ÿé¤Šæ€§ç”œå‘³åŠ‘ï¼šå±±æ¢¨ç³–é†‡** ï¼ˆSorbitolï¼‰ã€**æœ¨ç³–é†‡** ï¼ˆXylitolï¼‰ã€**èµ¤è—»é†£é†‡** ï¼ˆErythritolï¼‰ ç­‰ã€‚

**â‘¡****éç‡Ÿé¤Šæ€§ç”œå‘³åŠ‘ï¼šé˜¿æ–¯å·´ç”œ** ï¼ˆAspartameï¼‰ã€**ä¹™é†¯ç£ºèƒºé…¸é‰€** ï¼ˆAcesulfame potassiumï¼‰ã€**ä¸‰æ°¯è”—ç³–** æˆ–**è”—ç³–ç´ ** ï¼ˆSucraloseï¼‰ã€**ç³–ç²¾** ï¼ˆSaccharinï¼‰ç­‰ã€‚

**â‘¢éç‡Ÿé¤Šæ€§ç”œå‘³åŠ‘ï¼šç”œèŠç³–** ï¼ˆSteviaï¼‰ã€**é˜¿æ‹‰ä¼¯ç³–** ï¼ˆArabinoseï¼‰ç­‰ã€‚

æœ‰ç ”ç©¶ç™¼ç¾**éç‡Ÿé¤Šæ€§ç”œå‘³åŠ‘** ä¸­**ç’°å·²åŸºæ°¨åŸºç£ºé…¸éˆ‰** ï¼ˆä¿—ç¨±ç”œèœœç´ ï¼‰å’Œ**ä¹™é†¯ç£ºèƒºé…¸é‰€** ï¼ˆä¿—ç¨±å®‰è³½èœœ ACE-Kï¼‰èƒ½é¡¯è‘—å»¶é•·ç·šèŸ²çš„å£½å‘½ï¼Œç”šè‡³æ•ˆæœé‚„èˆ‡åŠ‘é‡ç„¡é—œã€‚æ‰€ä»¥æœ‰äº›å» å•†å°±æœƒæ‰“è‘—é€™å€‹å£è™Ÿèªªä»£ç³–å¯ä»¥å»¶é•·å£½å‘½ã€‚

ä¸éä¹Ÿæœ‰ç ”ç©¶æŒ‡å‡ºä½¿ç”¨å¤§é‡çš„ä»£ç³–æœƒå°è‡´å‹•ç‰©é«”é‡å¢åŠ ï¼Œé€™æ˜¯å› ç‚ºä»£ç³–çš„ç”œå‘³é›–ä¸æœƒå°è‡´è¡€ç³–å‡é«˜ï¼Œå»æ˜“å½±éŸ¿å‘³è¦ºï¼Œä½¿å¾—é£Ÿç‰©æ”å–é‡å¢åŠ ï¼Œç›´æ¥åŠ é‡è‚¥èƒ–æ©Ÿç‡ã€‚

### **è€è—¥æ–°ç”¨**

å³ä½¿æœ‰è¨±å¤šæ–°å‰µçš„ç”ŸæŠ€å…¬å¸å˜—è©¦ç ”ç™¼ï¼Œèƒ½å¤ çœŸæ­£é–‹ç™¼å‡ºèª¿ç¯€è€åŒ–è—¥ç‰©çš„å»å¾ˆå°‘ï¼›å°±ç®—æ ¸å‡†ä¸Šå¸‚äº†ï¼Œé‡å°å¤šé‡èº«é«”ç³»çµ±çš„è—¥ç‰©ï¼Œä¹Ÿå¯èƒ½æœƒåœ¨èº«é«”ç—…æ³ç¹å¤šçš„è€åŒ–æ—ç¾¤ä¸­ç”¢ç”Ÿæ–°çš„å‰¯ä½œç”¨ï¼Œæ‰€ä»¥è—¥å» çš„è…¦ç­‹å°±å‹•åœ¨ã€Œè€è—¥ã€ä¸Šã€‚

å› ç‚ºè€è—¥å·²ç¶“åšéäº†äººé«”è©¦é©—ï¼Œåªè¦æ‰¾åˆ°æ–°çš„æ²»ç™‚æ–¹å¼å°±èƒ½åŠ é€Ÿè—¥ç‰©é–‹ç™¼çš„éç¨‹ï¼Œå¾è€Œæ¸›å°‘æˆæœ¬ï¼Œè€Œä¸”é‚„ç‚ºæœªæ»¿è¶³çš„é†«ç™‚éœ€æ±‚ï¼Œæä¾›æ–°çš„æ²»ç™‚æ–¹æ³•ã€‚

ç¾åœ¨çŸ¥é“æ¯å¤©æœç”¨ä½åŠ‘é‡çš„**é˜¿æ–¯åŒ¹éˆ** ï¼ˆAspirinï¼‰å¯ä»¥é é˜²åŠæ€§å¿ƒè¡€ç®¡ç–¾ç—…å¤–ï¼Œç›®å‰åƒæ˜¯**é›·å¸•é»´ç´ ** ï¼ˆRapamycinï¼‰ã€**äºŒç”²é›™èƒ** ï¼ˆmetforminï¼‰ç­‰åœ¨å‹•ç‰©å¯¦é©—ä¸Šæœ‰é¡¯è‘—çš„æ•ˆæœã€‚

#### **é›·å¸•é»´ç´ ï¼ˆRapamycinï¼‰**

é›·å¸•é»´ç´  

è—¥åç‚º**é›·å¸•é»´ç´ ** ï¼ˆRapamuneï¼‰ï¼Œåˆå**è¥¿ç¾…è«å¸** ï¼ˆSirolimusï¼‰ï¼Œç¾ä¸»è¦é‹ç”¨æ–¼è…ç§»æ¤çš„æŠ—æ’æ–¥æ²»ç™‚ã€‚åŸæœ¬æ˜¯ç ”ç©¶å“¡åœ¨å¾©æ´»ç¯€å³¶æ¡é›†äº†ä¸€ä»½åœŸå£¤æ¨£æœ¬ï¼Œä»¥å°‹æ±‚ç ”ç™¼æ–°å‹æŠ—ç”Ÿç´ ã€‚

è¥¿å…ƒ 2001 å¹´å—åŠ å·å¤§å­¸çš„ç”Ÿç‰©å­¸å®¶ **ç“¦çˆ¾ç‰¹ï¼éš†æˆˆ** ï¼ˆValter Longoï¼‰é€±æœ«å‰å¿˜è¨˜é¤µé£Ÿå¯¦é©—ä¸­çš„ä¸€æ‰¹é…µæ¯èŒï¼Œçµæœä»¤ä»–å¤§åƒä¸€é©šï¼šå®Œå…¨ç¦é£Ÿä¸€æ®µæ™‚é–“çš„é…µæ¯èŒæ´»å¾—æ›´ä¹…ã€‚ä»–ç™¼ç¾å…¶ä¸­åŸå› èˆ‡ mTOR é€™é¡é…µç´ æ‰€è² è²¬çš„ä¸€é€£ä¸²åˆ†å­æ©Ÿåˆ¶æœ‰é—œã€‚

è¥¿å…ƒ 2009 å¹´ç§‘å­¸å®¶ç™¼ç¾é›·å¸•é»´ç´ èƒ½å¹²æ“¾å“ºä¹³å‹•ç‰© mTOR çš„è›‹ç™½è³ªæ´»æ€§ï¼Œå¤§å¹…å»¶é•·å°é¼ çš„å£½å‘½ã€‚

æœ‰ä¸‰å€‹å¯¦é©—å®¤å…±åŒå®£ä½ˆï¼Œå…·æœ‰æŠ‘åˆ¶ç´°èƒç”Ÿé•·ç‰¹æ€§çš„é›·å¸•é»´ç´ å¯å°‡å°é¼ çš„å£½å‘½å»¶é•· 12 %ï¼Œä»–å€‘åœ¨ç¾åœ‹åœ‹å®¶è€åŒ–ç ”ç©¶æ‰€çš„è´ŠåŠ©ä¸‹ï¼Œåˆ†åˆ¥ç²å¾—äº†ç›¸åŒçš„å¯¦é©—çµæœã€‚æœ€é©šå¥‡çš„æ˜¯ï¼Œé›·å¸•é»´ç´ å°é‚£äº›çœ‹èµ·ä¾†åš´é‡è€åŒ–çš„è€é¼ ä¹Ÿæœ‰æ•ˆï¼Œå¯å°‡ç‰ å€‘å¹³å‡çš„å­˜æ´»ç‡æé«˜ 1/3 ã€‚

è€Œè¥¿å…ƒ 2022 å¹´å¾·åœ‹ç ”ç©¶åœ˜éšŠåœ¨ã€Šè‡ªç„¶ã€‹å­æœŸåˆŠä¸Šç™¼è¡¨ä¸€ç¯‡è«–æ–‡ï¼Œå¯¦é©—ä¸­ç™¼ç¾åœ¨é’å£¯å¹´çš„æœè …å’Œå°é¼ èº«ä¸Šï¼Œåªè¦**æ—©æœŸçŸ­æš«æœç”¨** é›·å¸•é»´ç´ å°±èƒ½ç²å¾—èˆ‡**é•·æœŸçµ‚èº«æœç”¨** è©²è—¥ç‰©é¡ä¼¼çš„å»¶é•·å£½å‘½å’Œæ¸›å°‘è¡°è€ç›¸é—œç–¾ç—…çš„æ•ˆæœã€‚

åŒå¹´åœ¨ã€Šè‡ªç„¶ã€‹å­æœŸåˆŠä¸Šå¦å¤–ä¸€ç¯‡è«–æ–‡é¡¯ç¤ºï¼Œçµåˆç†±é‡é™åˆ¶é£²é£Ÿæ³•å’Œé›·å¸•éœ‰ç´ æ²»ç™‚ï¼Œèƒ½å¤Ÿæ›´å¥½åœ°æ¸›ç·©è€å¹´å°é¼ çš„è‚Œè‚‰è¡°é€€ã€‚

è¥¿å…ƒ 2018 å¹´ç¾åœ‹è«¾è¯ç”Ÿç‰©é†«å­¸ç ”ç©¶æ‰€ï¼ˆNovartis Institutes for Biomedical Researchï¼‰ç§‘å­¸å®¶è¨­è¨ˆçš„è—¥ç‰©ï¼ˆä¸€ç¨®é›·å¸•é»´ç´ çš„è¡ç”Ÿç‰©ï¼‰å¯ä»¥æ¢å¾©å…ç–«ç³»çµ±ï¼Œä¿è­·è€å¹´äººå…å—æ½›åœ¨è‡´å‘½çš„å‘¼å¸é“æ„ŸæŸ“ã€‚

ç ”ç©¶åœ˜éšŠæ‰¾ä¾† 264 å 65 æ­²ä»¥ä¸Šçš„äººåƒèˆ‡å¯¦é©—ï¼Œé€£çºŒ 6 é€±æ¥å—ä½åŠ‘é‡æŠ—è¡°è€è—¥ç‰©èˆ‡æœç”¨å®‰æ…°åŠ‘çš„çµæœæ¯”è¼ƒï¼Œç™¼ç¾æœç”¨æŠ—è¡°è€è—¥ç‰©çš„äººæœªä¾†ä¸€å¹´æ„Ÿå†’æ¬¡æ•¸åªæœ‰æ¥å—å®‰æ…°åŠ‘çš„å°ç…§çµ„çš„ä¸€åŠï¼Œä¸”æ¥ç¨®æŠ—è¡°è€è—¥ç‰©å¾Œçš„ä¸€å€‹æœˆï¼Œè¡€æ¶²ä¸­çš„æŠ—é«”å¢åŠ  20%ã€‚

ä¸éç”±æ–¼é›·å¸•é»´ç´ æœ‰ä¸€äº›å‰¯ä½œç”¨ï¼Œå®ƒæœƒæŠ‘åˆ¶äº†å…ç–«åæ‡‰ï¼Œä¸€äº›ç—…äººå£è…”ç”Ÿç˜¡ï¼Œä»¥åŠå‡ºç¾å…¶ä»–æ„ŸæŸ“ç—‡ç‹€ã€‚å°é¼ å¯¦é©—ä¸­ï¼Œé›„æ€§å°é¼ ä¼¼ä¹é‚„å‡ºç¾äº†çªä¸¸èç¸®çš„æƒ…å½¢ã€‚

#### **äºŒç”²é›™èƒï¼ˆMetforminï¼‰**

äºŒç”²é›™èƒ 

äºŒç”²é›™èƒåŸæœ¬æ˜¯æ²»ç™‚ç¬¬äºŒå‹ç³–å°¿ç—…çš„ä¸€ç·šè—¥ç‰©ï¼Œç‰¹åˆ¥æ˜¯é‡å°é«”é‡éé‡çš„æ‚£è€…ã€‚

**å–®ç£·é…¸è…ºè‹·æ´»åŒ–è›‹ç™½è³ªæ¿€é…¶** ï¼ˆAMP activated protein kinase, AMPKï¼‰æ˜¯ç´°èƒä¸­èª¿æ§èƒ½é‡å¹³è¡¡çš„é—œéµé…µç´ ï¼Œç´°èƒå¯è—‰ç”±æ´»åŒ–AMPK ï¼Œé™ä½åˆæˆä»£è¬åæ‡‰ã€‚äºŒç”²é›™èƒèƒ½æ´»åŒ– AMPKï¼Œåœ¨è€é¼ å’Œç³–å°¿ç—…æ‚£è€…ç ”ç©¶ä¸­ï¼Œéƒ½ç™¼æ®äº†å»¶é•·å£½å‘½çš„æ•ˆæœã€‚

è¥¿å…ƒ 2014 å¹´ï¼Œä¸€ä»½é‡å°è¿‘ 10 è¬åç³–å°¿ç—…æ‚£è€…çš„è‘—ååˆ†æå ±å‘ŠæŒ‡å‡ºæœç”¨äºŒç”²é›™èƒçš„ç—…äººï¼Œä¸ä½†å¥åº·ç‹€æ³æ˜é¡¯æ›´å¥½ï¼Œè€Œä¸”ä»–å€‘çš„å¹³å‡å£½å‘½é‚„è¶…éäº†éç³–å°¿ç—…æ‚£è€…ã€‚

æ‰€ä»¥åŒå¹´åœ¨æŠ—è¡°è€ç•ŒåŸ·ç‰›è€³çš„ç¾åœ‹**é«˜é½¡åŒ–ç ”ç©¶æ‰€** ï¼ˆNational Institute for Agingï¼ŒNIAï¼‰ç”³è«‹ä¸€é …ç ”ç©¶å‘½åç‚ºã€Œ**äºŒç”²é›™èƒé•·å£½ç ”ç©¶** ã€ï¼ˆMetformin In Longevity Studyï¼ŒMILESï¼‰çš„å¯¦é©—ã€‚

éš”å¹´ï¼Œç¾åœ‹**é«˜é½¡åŒ–ç ”ç©¶æ‰€** ï¼ˆNational Institute for Agingï¼ŒNIAï¼‰æš¨**è€åŒ–ç ”ç©¶è¯ç›Ÿ** ï¼ˆAmerican Federation for Aging Researchï¼ŒAFARï¼‰çš„**å°¼çˆ¾ï¼å·´èŒ²èŠ** ï¼ˆ Nir Barzilaiï¼‰åšå£«åˆç”³è«‹ä¸€é …ç ”ç©¶è²»ç”¨é«˜é” 7500 è¬ç¾é‡‘ï¼Œè¨ˆåŠƒé‡å° 3000 å 65~79 æ­²çš„æˆå¹´äººé€²è¡Œä¸€é …å…­å¹´å‘½åç‚ºã€Œ**ç”¨äºŒç”²é›™èƒé¶å‘è¡°è€** ã€ï¼ˆTargeting Aging by MEtforminï¼ŒTAMEï¼‰çš„ç ”ç©¶ï¼Œå…¶ä¸­ä¸€åŠå°‡æ¯å¤©æœç”¨äºŒç”²é›™èƒç‰‡ï¼Œå¦ä¸€åŠæœç”¨å®‰æ…°åŠ‘ï¼Œä¹Ÿæ˜¯**ç¬¬ä¸€å€‹** ä»¥æŠ—è¡°è€ç‚ºå**è‡¨åºŠç ”ç©¶** çš„è—¥ç‰©ã€‚

è¥¿å…ƒ 2017 å¹´ä¸€é …é‡å° 4.1 è¬å¤šåç”·æ€§äºŒç”²é›™èƒä½¿ç”¨è€…çš„ç ”ç©¶ç™¼ç¾ï¼ŒäºŒç”²é›™èƒå¯ä»¥é¡¯è‘—é™ä½åƒèˆ‡è€…æ‚£ç™¡å‘†ç—‡ã€ç™Œç—‡å’Œå¿ƒè¡€ç®¡ç–¾ç—…çš„é¢¨éšªã€‚

è¥¿å…ƒ 2023 å¹´ä¸­åœ‹åŒæ¿Ÿå¤§å­¸ï¼ˆTongJi Universityï¼‰åœ˜éšŠåœ¨ã€Šå¾®ç”Ÿç‰©é«”ã€‹ä¸Šç™¼è¡¨æœ€æ–°ç ”ç©¶æ­ç¤ºäº†ã€ŒäºŒç”²é›™èƒæ”¹å–„å¤§è…¦èªçŸ¥åŠŸèƒ½ã€çš„æ·±å±¤æ©Ÿåˆ¶ã€‚åœ¨äºŒç”²é›™èƒçš„å½±éŸ¿ä¸‹ï¼Œèšé›†åœ¨è…¸é“å¾®ç”Ÿç‰©ç¾¤ä¸­çš„æœ‰ç›ŠèŒ AKK èŒé€éæ¸›â€‹â€‹å°‘ä¿ƒç‚ç´°èƒå› å­**ç™½ä»‹ç´ -6** ï¼ˆInterleukin-6, IL-6ï¼‰ä¾†èª¿ç¯€å®¿ä¸»é«”å…§èˆ‡ç™¼ç‚ç›¸é—œçš„é€šè·¯ï¼Œå¾è€Œæ”¹å–„äº†è€å¹´å°é¼ çš„èªçŸ¥åŠŸèƒ½ã€‚
    
    
    è¥¿å…ƒ 2023 å¹´ç™¼è¡¨åœ¨ã€Šè‡ªç„¶ã€‹å­åˆŠç¸½çµäº†äºŒç”²é›™èƒåœ¨ä¸åŒç–¾ç—…é ˜åŸŸä¸­çš„æœ€æ–°ç™¼ç¾ï¼Œå°åˆ°ç§€éº—éš±æ¡¿ç·šèŸ²å’Œé»‘è…¹æœè …ï¼Œå¤§åˆ°ä¸€äº›é€²é£Ÿé¡å‹•ç‰©ï¼Œçµæœå‡é¡¯ç¤ºï¼šäºŒç”²é›™èƒèƒ½å¤ å»¶é•·ä¸­ä½æ•¸å’Œæœ€é«˜å£½å‘½ã€‚  
    

ä¸éå°æ–¼ç¾ä»£äººä¾†èªªï¼Œè¦æŠŠè—¥ç•¶æˆæ˜¯å¿…éœ€å“é‚„æœ‰ä¸€æ®µè·¯è¦èµ°ã€‚

## **ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„åˆç‰©çš„èª•ç”Ÿ**

å¤šé…šé¡æ—¢ç„¶æœ‰å¦‚æ­¤æ•ˆæœï¼Œé‚£æœƒä¸æœƒæœ‰ä¸­è‰è—¥ç‰©æˆ–è€…æ˜¯é£Ÿç‰©å…§ä¹Ÿæœ‰ç›¸åŒçš„ä½œç”¨ï¼Œè€Œä¸”æ›´å°‘å‰¯ä½œç”¨å‘¢ï¼Ÿ

ç¶ èŒ¶å…§çš„å…’èŒ¶ç´ å¦‚æœæ­é…è–‘é»ƒç´ åˆæ˜¯å¦‚ä½•ï¼Ÿ

ç”¨äº†å…’èŒ¶ç´ æœƒä¸æœƒèˆ‡å…¶ä»–çš„æŠ—è¡°è€è—¥ç‰©èµ·è¡çªï¼Ÿ

ç§‘å­¸å®¶å€‘å˜—è©¦åˆ©ç”¨**å¤šç¨®ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„æˆçš„** ã€Œ**é…æ–¹** ã€ä¾†å½±éŸ¿æ›´å¤šè€åŒ–ç›¸é—œçš„åŸºå› è¡¨é”ï¼ŒåŒæ™‚ä¹Ÿèª¿æ•´é…æ–¹å¸Œæœ›ä¹Ÿé™ä½å…¶ä»–çµ„åˆçš„ç›¸è¡çªã€‚

æˆ‘è¦ºå¾—é€™å€‹æ˜¯æœ€é‡è¦çš„å·®ç•°ã€‚

**å› ç‚ºå–®ä¸€æˆä»½å½±éŸ¿çš„å±¤é¢å¤ªå»£ï¼Œä¹Ÿä¸å¯èƒ½é¢é¢ä¿±åˆ°ï¼Œä¹Ÿæœ‰å¯èƒ½åœ¨ä¸åŒçš„è¨Šæ¯å‚³éæ©Ÿåˆ¶ä¸­ç›¸äº’å¹²æ“¾ã€‚**

é€™æ™‚å€™å°±éœ€è¦**ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„åˆç‰©** ç›¸è¼”ç›¸æˆã€‚

åœ¨æœ€æ–°è¥¿å…ƒ 2020 å¹´çš„ç ”ç©¶å ±å‘ŠæŒ‡å‡ºï¼Œä»–å€‘å¾è¶…é 50 ç¨®å…·æœ‰ç†±é‡é™åˆ¶æ•ˆæœçš„å¤©ç„¶ç‰©ä¸­æŒ‘é¸äº†å…¶ä¸­ 15 å€‹ç•¶ä½œç‡Ÿé¤Šç´ æ··åˆç‰©æ··åœ¨é£²é£Ÿå…§çµ¦è€é¼ é£Ÿç”¨ï¼Œå°æ–¼å¤§è…¦çš®è³ªã€å¿ƒè‡Ÿèˆ‡è‚Œè‚‰éƒ½æ¯”åšå¡è·¯é‡Œé™åˆ¶æœ‰æ›´å¥½çš„æ•ˆæœï¼›

ä¸åƒ…åœ¨ç·šèŸ²ä¸Šé‚„èƒ½å¤ å¢åŠ æ´»å‹•åŠ›èˆ‡å¢é•·å£½å‘½ï¼Œåœ¨å°‘é‡æ•¸ç›®çš„äººé«”é›™ç›²å¯¦é©—ä¸­ï¼Œè­‰å¯¦å¯ä»¥å¢åŠ è…¦ä¸­çš„ç©€èƒ±ç”˜è‚½ï¼Œä»¥åŠå°å¤§è…¦çš„èªçŸ¥åŠŸèƒ½çš„æ”¹å–„ä¹Ÿæœ‰å¥½çš„è¡¨ç¾ã€‚

ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„åˆç‰©åˆ—è¡¨

## **ç¥å¥‡è—¥ä¸¸ï¼ˆMagic Pillï¼‰**

åœ¨èƒ½è­‰æ˜ç†±é‡é™åˆ¶æ¨¡æ“¬ç‰©çµ„åˆç‰©èƒ½å»¶å¹´ç›Šå£½ä¹‹å‰ï¼Œä¸Šè¿°çµ„åˆèƒ½å¤ èª¿æ•´æˆ‘å€‘å¥åº·ç‹€æ…‹ï¼Œå¢å¼·èº«é«”æ©Ÿèƒ½ã€‚

ä¸Šé¢é…æ–¹ç¾åœ¨å°±å¯ä»¥è²·å¾—åˆ°ï¼Œä½ é¡˜æ„æœç”¨å—ï¼Ÿæ­¡è¿ç•™è¨€è¡¨ç¤ºä½ çš„çœ‹æ³•ï¼

å¿…å‚™è‰¯è—¥

> [è¶…è¶Šå„„è¬å¯Œè±ªä½¿ç”¨çš„æŠ—è¡°è€ç‡Ÿé¤Šé…æ–¹ã€ŒageLOC Youthspan ã€ä¹ä½ é€†è½‰å‹](https://agelocked.com/%e8%b6%85%e8%b6%8a%e5%84%84%e8%90%ac%e5%af%8c%e8%b1%aa%e4%bd%bf%e7%94%a8%e7%9a%84%e6%8a%97%e8%a1%b0%e8%80%81%e7%87%9f%e9%a4%8a%e9%85%8d%e6%96%b9%e3%80%8cageloc-youthspan-%e3%80%8d%e4%b9%8e%e4%bd%a0/)

åƒè€ƒè³‡æ–™ï¼š  
01.å­¸ç¿’åŠ æ²¹ç«™/[ç…‰ä¸¹è¡“](http://163.28.10.78/content/junior/phy_chem/ty_lk/sir/content/cphc/cphc2/cphc23.htm)  
02.æ¯æ—¥é ­æ¢/[å¤ä»£çš„æ–¹å£«ç‚ºä½•ç¸½æ•™çš‡å¸æœé£Ÿä¸¹è—¥ï¼Œè€Œä¸å»æ•™çš‡å¸ä¿®ç…‰å…§ä¸¹è¡“ï¼Ÿ](https://kknews.cc/history/p2k5olj.html)  
03.æ¯æ—¥é ­æ¢/[å°‹æ±‚é•·ç”Ÿä¸è€è—¥è€Œèˆˆèµ·çš„ç…‰ä¸¹è¡“æˆå°±äº†ç¡ƒç ‚](https://kknews.cc/culture/2m6vgxg.html)  
04.æ¯æ—¥é ­æ¢/[é—œæ–¼é•·ç”Ÿä¸æ­»è—¥ï¼Œä½ äº†è§£å—](https://kknews.cc/zh-tw/culture/ezzgpm4.html)  
05.ç—å®¢é‚¦/Nanobio/[çœŸæœ‰é•·ç”Ÿä¸è€è—¥å—? (1) Resveratrolä¹‹ä»‹ç´¹](https://nanobio.pixnet.net/blog/post/24587450)  
06.ç—å®¢é‚¦/Nanobio/[çœŸæœ‰é•·ç”Ÿä¸è€è—¥å—? (2) GSKå›§äº†](https://nanobio.pixnet.net/blog/post/24806128)  
07.ç§‘å­¸Online/[ç´…é…’å¯ä»¥å»¶å¹´ç›Šå£½ï¼Ÿ](https://highscope.ch.ntu.edu.tw/wordpress/?p=37949)  
08.çŸ¥ä¹/æ™‚å…‰æ´¾/[å‰æ²¿å¿«è®¯ï¼šâ€œä¸è€è¯â€NMNå’ŒNRçš„æœ¬è´¨ï¼Œå››å·å¤§å­¦å›¢é˜Ÿä¸ºä½ è®²è§£å…³äºNAD+çš„ä¸€åˆ‡](https://zhuanlan.zhihu.com/p/267696603)  
09.çŸ¥ä¹/æ™‚å…‰æ´¾/[æå˜‰è¯šçš„â€œä¸è€è¯â€æœ‰å“ªäº›åŠŸæ•ˆï¼Ÿå››å·å¤§å­¦æœ€æ–°æœ€å…¨è§£](https://zhuanlan.zhihu.com/p/274379409)  
10.çŸ¥ä¹/æ™‚å…‰æ´¾/[å»¶é•¿å¯¿å‘½è¾¾19%ï¼è¿™é¢—é•¿å¯¿ä»™ä¸¹ä¼ ç”·ä¸ä¼ å¥³ï¼ç”·åŒå¿—é€Ÿè¿›](https://zhuanlan.zhihu.com/p/393894009)  
11\. Catalina AlarcÃ³n de la Lastra, Isabel Villegas, 2005. [Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications.](https://pubmed.ncbi.nlm.nih.gov/15832402/) _Mol Nutr Food Res._ 49(5):405-30.  
12\. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH, 2007. [Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.](https://pubmed.ncbi.nlm.nih.gov/18046409/)_Nature_. 450(7170):712-716.  
13\. Dan-Dan Zhou, Min Luo, Si-Yu Huang, Adila Saimaiti, Ao Shang, Ren-You Gan, Hua-Bin Li, 2021. [Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases.](https://pubmed.ncbi.nlm.nih.gov/34336123/) _Oxid Med Cell Longev._ 9932218.  
14\. Zeynab Kohandel, Majid Darrudi, Kobra Naseri, Fariborz Samini, Michael Aschner, Ali Mohammad Pourbagher-Shahri, Saeed Samarghandian, 2023. [The Role of Resveratrol in Aging and Senescence: A Focus on Molecular Mechanisms.](https://pubmed.ncbi.nlm.nih.gov/37278035/) _Curr Mol Med._   
15\. Ana P. Gomes, Nathan L. Price, Alvin J.Y. Ling, Javid J. Moslehi, Magdalene K. Montgomery, Luis Rajman, James P. White, JoÃ£o S. Teodoro, Christiane D. Wrann, Basil P. Hubbard, Evi M. Mercken, Carlos M. Palmeira, Rafael de Cabo, Anabela P. Rolo, Nigel Turner, Eric L. Bell, and David A. Sinclair, 2013. [Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076149/) _Cell_. 155(7): 1624â€“1638.  
16\. Jun Li, Michael S Bonkowski, SÃ©bastien Moniot, Dapeng Zhang, Basil P Hubbard, Alvin J Y Ling, Luis A Rajman, Bo Qin, Zhenkun Lou, Vera Gorbunova, L Aravind, Clemens Steegborn, David A Sinclair, 2017.[ A conserved NAD+ binding pocket that regulates protein-protein interactions during aging](https://pubmed.ncbi.nlm.nih.gov/28336669/). _Science_. 355(6331):1312-1317.  
17\. David E Harrison, Randy Strong, Peter Reifsnyder, Navasuja Kumar, Elizabeth Fernandez, Kevin Flurkey, Martin A Javors, Marisa Lopez-Cruzan, Francesca Macchiarini, James F Nelson, Alessandro Bitto, Amy L Sindler, Gino Cortopassi, Kylie Kavanagh, Lin Leng, Richard Bucala, Nadia Rosenthal, Adam Salmon, Timothy M Stearns, Molly Bogue, Richard A Miller, 2021. [17-a-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex.](https://pubmed.ncbi.nlm.nih.gov/33788371/) _Aging Cell_. 20(5):e13328.  
18\. David E. Harrison, Randy Strong, Zelton Dave Sharp, James F. Nelson, Clinton M. Astle, Kevin Flurkey, Nancy L. Nadon, J. Erby Wilkinson, Krystyna Frenkel, Christy S. Carter, Marco Pahor, Martin A. Javors, Elizabeth Fernandez, and Richard A. Miller, 2009. [Rapamycin fed late in life extends lifespan in genetically heterogeneous mice.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786175/) _Nature_. 460(7253): 392â€“395.  
19\. Joan B Mannick, Melody Morris, Hans-Ulrich P Hockey, Guglielmo Roma, Martin Beibel, Kenneth Kulmatycki, Mollie Watkins, Tea Shavlakadze, Weihua Zhou, Dean Quinn, David J Glass, Lloyd B Klickstein, 2018. [TORC1 inhibition enhances immune function and reduces infections in the elderly.](https://pubmed.ncbi.nlm.nih.gov/29997249/) _Trial Sci Transl Med._ 10(449):eaaq1564.   
20\. Paula Juricic, Yu-Xuan Lu, Thomas Leech, Lisa F Drews, Jonathan Paulitz, Jiongming Lu, Tobias Nespital, Sina Azami, Jennifer C Regan, Emilie Funk, Jenny FrÃ¶hlich, Sebastian GrÃ¶nke, Linda Partridge, 2022. [Long-lasting geroprotection from brief rapamycin treatment in early adulthood by persistently increased intestinal autophagy.](https://pubmed.ncbi.nlm.nih.gov/37118497/) _Nat Aging._ 2(9):824-836.  
21\. Daniel J Ham, Anastasiya BÃ¶rsch, Kathrin Chojnowska, Shuo Lin, Aurel B Leuchtmann, Alexander S Ham, Marco ThÃ¼rkauf, Julien Delezie, Regula Furrer, Dominik Burri, Michael Sinnreich, Christoph Handschin, Lionel A Tintignac, Mihaela Zavolan, Nitish Mittal, Markus A RÃ¼egg, 2022. [Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscle.](https://pubmed.ncbi.nlm.nih.gov/35440545/) _Nat Commun._ 13(1):2025.  
22\. Ameya S Kulkarni, Sriram Gubbi, Nir Barzilai, 2020. [Benefits of Metformin in Attenuating the Hallmarks of Aging.](https://pubmed.ncbi.nlm.nih.gov/32333835/) _Cell Metab._ 32(1): 15â€“30.  
23\. Lucydalila Cedillo, Fasih M Ahsan, Sainan Li, Nicole L Stuhr, Yifei Zhou, Yuyao Zhang, Adebanjo Adedoja, Luke M Murphy, Armen Yerevanian, Sinclair Emans, Khoi Dao, Zhaozhi Li, Nicholas D Peterson, Jeramie Watrous, Mohit Jain, Sudeshna Das, Read Pukkila-Worley, Sean P Curran, Alexander A Soukas, 2023. [Ether lipid biosynthesis promotes lifespan extension and enables diverse pro-longevity paradigms in  _Caenorhabditis elegans_.](https://pubmed.ncbi.nlm.nih.gov/37606250/) _Elife._ 12:e82210.  
24\. Luo S, Wong ICK, Chui CSL, Zheng J, Huang Y, Schooling CM, Yeung SLA, 2023. [Effects of putative metformin targets on phenotypic age and leukocyte telomere length: a mendelian randomisation study using data from the UK Biobank.](https://pubmed.ncbi.nlm.nih.gov/37421961/) _Lancet Healthy Longev._ 4(7):e337-e344.  
25\. Xiaoqi Zhu, Junyan Shen, Shengyu Feng, Ce Huang, Hao Wang, Fengjiao Huo, Hailiang Liu, 2023. [Akkermansia muciniphila, which is enriched in the gut microbiota by metformin, improves cognitive function in aged mice by reducing the proinflammatory cytokine interleukin-6.](https://pubmed.ncbi.nlm.nih.gov/37254162/) _Microbiome._ 11(1):120.  
26\. Marra PS, Yamanashi T, Crutchley KJ, Wahba NE, Anderson ZM, Modukuri M, Chang G, Tran T, Iwata M, Cho HR, Shinozaki G, 2023. [Metformin use history and genome-wide DNA methylation profile: potential molecular mechanism for aging and longevity.](https://pubmed.ncbi.nlm.nih.gov/36734879/) _Aging (Albany NY)._ 15(3):601-616.  
27\. Frank Madeo, Didac Carmona-Gutierrez, Sebastian J. Hofer, and Guido Kroemer,2019. [Caloric Restriction Mimetics against Age-Associated Disease:Targets, Mechanisms, and Therapeutic Potential.](https://pubmed.ncbi.nlm.nih.gov/30840912/) _Cell Metab._ 29(3):592-610.  
28\. George S Roth, Mark A Lane, Donald K Ingram, 2005. [Caloric Restriction Mimetics: The Next Phase.](https://pubmed.ncbi.nlm.nih.gov/16399906/) _Ann N Y Acad Sci._ 1057:365-71.  
29\. Donald K Ingram, Min Zhu, Jacek Mamczarz, Sige Zou, Mark A Lane, George S Roth, Rafael deCabo, 2005. [Calorie restriction mimetics: an emerging research field. ](https://pubmed.ncbi.nlm.nih.gov/16626389/)_Aging Cell._ 5(2):97-108.  
30\. Hideya Shintani, Tomoya Shintani, Hisashi Ashida, Masashi Sato, 2018[. Calorie Restriction Mimetics: Upstream-Type Compounds for Modulating Glucose Metabolism.](https://pubmed.ncbi.nlm.nih.gov/30469486/) _Nutrients._ 10(12):1821.  
31\. Frank Madeo, Federico Pietrocola, Tobias Eisenberg, Guido Kroemer, 2014. [Caloric restriction mimetics: towards a molecular definition.](https://pubmed.ncbi.nlm.nih.gov/25212602/) _Nat Rev Drug Discov_. 13(10):727-40.  
32\. Shin-Hae Lee and Kyung-Jin Min, 2013. [Caloric restriction and its mimetics.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133883/) _BMB Rep._ 46(4): 181â€“187.  
33\. Christoph Handschin, 2016. [Caloric restriction and exercise â€œmimeticsâ€™â€™: Ready for prime time?](https://pubmed.ncbi.nlm.nih.gov/26658171/) _Pharmacol Res._ 103:158-66.  
34\. Randy Strong, Richard A Miller, Adam Antebi, Clinton M Astle, Molly Bogue, Martin S Denzel, Elizabeth Fernandez, Kevin Flurke, Karyn L Hamilton, Dudley W Lamming, Martin A Javors, JoÃ£o Pedro de MagalhÃ£es, Paul Anthony Martinez, Joe M McCord, Benjamin F Miller, Michael MÃ¼ller, James F Nelson, Juliet Ndukum, G Ed Rainger, Arlan Richardson, David M Sabatini, Adam B Salmon, James W Simpkins, Wilma T Steegenga, Nancy L Nadon, David E Harrison, 2016. [Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an Î±-glucosidase inhibitor or a Nrf2-inducer.](https://pubmed.ncbi.nlm.nih.gov/27312235/) _Aging Cell_. 15(5):872-84.  
35\. Jamie L Barger, James M Vann, Nicole L Cray, Thomas D Pugh, Angela Mastaloudis, Shelly N Hester, Steven M Wood, Michael A Newton, Richard Weindruch, Tomas A Prolla, 2017. [Identification of tissue-specific transcriptional markers of caloric restriction in the mouse and their use to evaluate caloric restriction mimetics.](https://pubmed.ncbi.nlm.nih.gov/28556428/) _Aging Cell._ 16(4):750-760.  
36\. Eva Serna, Angela Mastaloudis, Patricia Martorell, Steven M Wood, Shelly N Hester, Mark Bartlett, Tomas A Prolla, Jose ViÃ±a, 2020. [A Novel Micronutrient Blend Mimics Calorie Restriction Transcriptomics in Multiple Tissues of Mice and Increases Lifespan and Mobility in  _C. elegans_.](https://pubmed.ncbi.nlm.nih.gov/32075050/) _Nutrients_. 12(2):486.  
37\. Mastaloudis A, Sheth C, Hester SN, Wood SM, Prescot A, McGlade E, Renshaw PF, Yurgelun-Todd, 2020. [Supplementation with a putative calorie restriction mimetic micronutrient blend increases glutathione concentrations and improves neuroenergetics in brain of healthy middle-aged men and women.](https://pubmed.ncbi.nlm.nih.gov/32335159/) _Free Radic Biol Med_. 153:112-121.  
38\. Ye Chen, Sherif Hamidu, Xintong Yang, Yiqi Yan, Qilong Wang, Lin Li, Patrick Kwabena Oduro, Yuhong Li, 2022. [Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging.](https://pubmed.ncbi.nlm.nih.gov/35571015/) _Front Genet._ 13:880421.

å–œæ­¡æˆ‘å¯«çš„å…§å®¹å—?  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€å‘Šè¨´æˆ‘ä½ çš„æ„Ÿæƒ³èˆ‡è©•è«– ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)

æƒ³ç¬¬ä¸€æ‰‹æ¥æ”¶ç”¢å“å¿«è¨Šèˆ‡ç§‘å­¸æ–°çŸ¥å—ï¼Ÿ  
æœ‰æ­é…å¦‚æ–°ä¿å¥å“å•é¡Œæƒ³å•å—ï¼Ÿ  
è«‹é»é¸åŠ å…¥å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤å°ˆå€åšè«®è©¢ ğŸ‘‡ğŸ‘‡ğŸ‘‡ğŸ‘‡  

[ å¦‚æ–°ä¿å¥å“å°ˆå®¶ageLOCå¤æœƒå“¡å°ˆå€ ](https://lin.ee/jgugMvX)
